Fingerprint
Dive into the research topics of 'Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic Leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically